{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/63323-322#drug","name":"Imipenem and Cilastatin","alternateName":"Imipenem and Cilastatin Sodium","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"63323-322"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"ANDA090577"},{"@type":"PropertyValue","propertyID":"UNII","value":"5428WXZ74M|71OTZ9ZE0A"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"6ab0ca9e-9a79-4cab-9f09-470eda06952e"}],"activeIngredient":"CILASTATIN SODIUM, IMIPENEM","administrationRoute":["INTRAVENOUS"],"dosageForm":"INJECTION, POWDER, FOR SOLUTION","manufacturer":{"@type":"Organization","name":"Fresenius Kabi USA, LLC"},"drugClass":[],"isAvailableGenerically":true,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/ANDA090577","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6ab0ca9e-9a79-4cab-9f09-470eda06952e","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-322"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-02T16:07:17.112Z"}}